An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
- PMID: 37074225
- PMCID: PMC10448559
- DOI: 10.4274/jcrpe.galenos.2023.2022-11-3
An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
Abstract
Objective: 22q11.2 deletion syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder. Associated problems in 22q11.2 DS may include cardiac abnormalities, immune dysfunction, facial dysmorphism, with endocrine, genitourinary and gastrointestinal problems, and developmental delay. The aim of this study was to evaluate and present all endocrinological findings of patients with 22q11.2 DS from a single center.
Methods: All participants had confirmed 22q11.2 DS by fluorescence in situ hybridization with hypoparathyroidism. Data were retrieved by retrospective review of patient records.
Results: A total of 17 patients were reviewed. On physical examination, all patients had similar dysmorphic features. The median age at diagnosis was 45 days (1 day-13 years). Most cases (64.7%, 11/17) were diagnosed with hypoparathyroidism incidentally after routine tests. At the time of diagnosis, mean calcium was 7.04±0.80 mg/dL, phosphorus was 6.2±1.1 mg/dL, and median parathyroid hormone (PTH) was 11.5 (3.7-47.6) ng/L. Transient hypoparathyroidism was detected in five cases (29.4%). There was no significant difference between patients with permanent or transient hypoparathyroidism regarding gender, age at diagnosis, calcium, phosphorus, and PTH levels. However, vitamin D levels were significantly lower in the transient group (p=0.036). During follow-up, short stature, obesity, and type 2 diabetes mellitus were absent. Thyroid autoantibodies were detected in two patients with normal thyroid function tests. Despite there being no pathological short stature, final stature was shorter than the general population (mean height standard deviation score: -0.94±0.83).
Conclusion: Hypocalcemia may be detected during acute illness in some cases where hypocalcemia appears at later ages. There was no significant difference between permanent and transient hypoparathyroidism cases in terms of PTH level. Recognition of the more specific facial findings is important to trigger investigation of genetic variants, additional anomalies, and for follow-up.
Keywords: 22q11.2 deletion syndrome; DiGeorge syndrome; Tetralogy of Fallot; hooded eyelids; hypoparathyroidism; immunodeficiency; vitamin D deficiency.
Conflict of interest statement
Figures
Similar articles
-
Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome.Front Endocrinol (Lausanne). 2022 Mar 31;13:771100. doi: 10.3389/fendo.2022.771100. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432203 Free PMC article.
-
Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome.Horm Res. 2005;63(6):294-9. doi: 10.1159/000086745. Epub 2005 Jul 1. Horm Res. 2005. PMID: 15995343
-
An Adult Case of Chromosome 22q11.2 Deletion Syndrome Associated with a High-positioned Right Aortic Arch.Intern Med. 2017;56(7):865-872. doi: 10.2169/internalmedicine.56.7558. Epub 2017 Apr 1. Intern Med. 2017. PMID: 28381757 Free PMC article.
-
22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes.Curr Opin Pediatr. 2001 Oct;13(5):465-72. doi: 10.1097/00008480-200110000-00014. Curr Opin Pediatr. 2001. PMID: 11801894 Review.
-
Hypoparathyroidism and late-onset hypogonadism in an adult male with familial 22q11.2 deletion syndrome: a case report with 3-year follow-up and review of the literature.BMC Endocr Disord. 2022 Nov 12;22(1):278. doi: 10.1186/s12902-022-01150-z. BMC Endocr Disord. 2022. PMID: 36371175 Free PMC article. Review.
Cited by
-
Early puberty paradox: an investigation of anxiety levels of mothers and children, children's quality of life, and psychiatric diagnoses.Eur J Pediatr. 2023 Aug;182(8):3775-3783. doi: 10.1007/s00431-023-05057-2. Epub 2023 Jun 19. Eur J Pediatr. 2023. PMID: 37335399
References
-
- McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) Medicine (Baltimore) 2011;90:1–18. - PubMed
-
- Butts SC. The facial phenotype of the velo-cardio-facial syndrome. Int J Pediatr Otorhinolaryngol. 2009;73:343–350. - PubMed
-
- Levy-Shraga Y, Gothelf D, Goichberg Z, Katz U, Somech R, Pinhas-Hamiel O, Modan-Moses D. Growth characteristics and endocrine abnormalities in 22q11.2 deletion syndrome. Am J Med Genet A. 2017;173:1301–1308. - PubMed
-
- Choi JH, Shin YL, Kim GH, Seo EJ, Kim Y, Park IS, Yoo HW. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res. 2005;63:294–299. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous